Article info
PDFThe risks of targeted therapies
Serious infections with antirheumatic therapy: are biologicals worse?
- Correspondence to:
K L Winthrop
Division of Infectious Diseases, School of Medicine, Oregon Health Sciences University, 3375 SW Terwilliger Boulevard, Portland, OR 97239-4197, USA; winthrop{at}ohsu.edu
Citation
Serious infections with antirheumatic therapy: are biologicals worse?
Publication history
- First published October 12, 2006.
Online issue publication
April 13, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2006 by Annals of the Rheumatic Diseases